You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • OP0023 Sarilumab for the treatment of moderate-to-severe rheumatoid arthritis: Results of a phase 2, randomized, double-blind, placebo-controlled, international study

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Oral Presentations
Abstract Session: Update on non anti-TNF biologics
OP0023 Sarilumab for the treatment of moderate-to-severe rheumatoid arthritis: Results of a phase 2, randomized, double-blind, placebo-controlled, international study

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 20142303
Mar 20141300
Apr 2014700
May 20141301
Jun 2014900
Jul 2014200
Aug 20141801
Sep 2014701
Oct 2014500
Nov 20141002
Dec 2014301
Jan 2015301
Feb 2015300
Mar 20151101
Apr 2015600
May 2015100
Jun 2015501
Jul 2015500
Aug 2015401
Sep 2015100
Oct 2015200
Nov 20151102
Dec 2015701
Jan 20161400
Feb 20161502
Mar 20161604
Apr 2016909
May 2016401
Jun 2016801
Jul 20161502
Aug 20161004
Sep 201623023
Oct 2016300
Nov 2016903
Dec 2016701
Jan 2017300
Feb 2017600
Mar 2017800
Apr 2017300
May 20171101
Jun 20172801
Jul 20172803
Aug 20171400
Sep 20171200
Oct 20172404
Nov 2017800
Dec 2017600
Jan 20181200
Feb 20181601
Mar 20182005
Apr 20181200
May 20184801
Jun 20181400
Jul 20181000
Aug 20183000
Sep 20181600
Oct 2018200
Nov 20181000
Dec 2018400
Jan 2019200
Feb 2019903
Mar 20195402
Apr 20191502
May 20191201
Jun 20191600
Jul 20192504
Aug 2019200
Sep 2019601
Oct 20192702
Nov 2019100
Dec 20191700
Jan 2020200
Feb 20201000
Mar 2020701
Apr 2020800
May 20201500
Jun 20202001
Jul 20201201
Aug 20201201
Sep 20201300
Oct 20201100
Nov 2020800
Dec 2020800
Jan 2021200
Feb 2021800
Mar 2021301
Apr 20211200
May 2021301
Jun 2021201
Oct 20211000
Nov 2021201
Dec 2021800
Jan 2022400
Feb 2022400
Mar 20221301
Apr 202210200
May 2022800
Jun 2022900
Jul 20222000
Aug 2022800
Sep 20221600
Oct 2022400
Nov 2022600
Dec 20223400
Jan 20231001
Feb 20231200
Mar 20235800
Apr 2023901
May 2023800
Jul 2023500
Aug 20231200
Sep 2023400
Oct 2023400
Nov 2023300
Dec 20231400
Jan 20241400
Feb 20246501
Mar 20242600
Total14810109